eYantra Ventures reported a massive 188% surge in consolidated revenue to Rs 94.22 crore for FY26. Despite this top-line growth, the company swung to a net loss of Rs 4.75 crore, primarily due to aggressive capital expenditure in AI-based IT services and healthcare verticals. The board has opted not to declare a dividend to preserve cash for scaling operations. Investors should focus on future margin recovery as the firm pivots toward high-margin proprietary AI products.
eYantra Ventures FY26 Revenue Hits Rs 94.22 Crore, Posts Net Loss
Consolidated Revenue at Rs 94.22 crore; Consolidated Net Loss of Rs 4.75 crore.
Reader Takeaway: Strong revenue growth driven by merchandising and AI product adoption faces short-term pressure from heavy strategic investments.
What just happened
eYantra Ventures has released its financial results for FY 2025-26, showcasing significant top-line expansion. Consolidated revenue grew to Rs 94.22 crore, up from Rs 32.70 crore in the previous year. However, the company reported a consolidated net loss of Rs 4.75 crore, a reversal from the profit seen in FY25. The standalone entity recorded a modest Profit After Tax of Rs 26.53 lakh.
Why this matters
The company is currently in an investment phase, prioritizing market share and proprietary technology over immediate bottom-line gains. The merchandising business, which grew 183% YoY to Rs 53.5 crore, remains the core revenue pillar. Simultaneously, the company is betting heavily on its AI-first transformation strategy, deploying proprietary platforms like 'AgentIQ' and 'VisionIQ'.
Business Highlights
- Merchandising segment reported Rs 53.5 crore in revenue, driven by enterprise orders.
- IT Services grew 21% YoY, focusing on digital transformation and AI integration.
- The board approved a scheme of arrangement to merge wholly-owned subsidiary Prismberry Technologies with the parent company, pending NCLT approval.
Corporate Changes
Mr. Rahul Rasa has joined as an Additional Director (Non-Executive) following the resignation of Mrs. Anajana Ramesh Thakker. Chairperson and Managing Director Mrs. Vinita Raj Narayanam has offered herself for re-appointment at the upcoming 41st AGM.
Risks to watch
Investors should closely monitor the sustainability of the company's cost structure. The current losses are attributed to high-intensity investments in the IT and healthcare verticals. Management has opted not to recommend a dividend for FY26 to conserve funds, signaling that the focus remains entirely on scaling operations for the near future.
What to track next
Watch for operational leverage in upcoming quarters. Shareholders will be looking for a transition from high expenditure to improved margins as these new AI product lines and healthcare investments begin to scale.